Healthcare provider profile · identity verified

Junji Henry Higuchi, MD

Internal Medicine · SAN ANTONIO, TX · NPI 1285742056

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	633	90
Sertraline Hcl	Sertraline Hcl	357	46
Gabapentin	Gabapentin	329	47
Metformin Hcl	Metformin Hcl	322	45
Levothyroxine Sodium	Levothyroxine Sodium	312	42
Eliquis	Apixaban	309	20
Donepezil Hcl	Donepezil Hcl	308	44
Divalproex Sodium	Divalproex Sodium	300	45
Lisinopril	Lisinopril	290	48
Amlodipine Besylate	Amlodipine Besylate	282	49
Memantine Hcl	Memantine Hcl	253	30
Furosemide	Furosemide	234	35
Metoprolol Tartrate	Metoprolol Tartrate	222	35
Potassium Chloride	Potassium Chloride	186	34
Trazodone Hcl	Trazodone Hcl	185	30
Levetiracetam	Levetiracetam	182	23
Simvastatin	Simvastatin	181	22
Oxcarbazepine	Oxcarbazepine	169	26
Carvedilol	Carvedilol	150	23
Escitalopram Oxalate	Escitalopram Oxalate	149	24
Mirtazapine	Mirtazapine	143	19
Famotidine	Famotidine	142	23
Losartan Potassium	Losartan Potassium	142	19
Pantoprazole Sodium	Pantoprazole Sodium	122	20
Risperidone	Risperidone	119	19
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	116	18
Lactulose	Lactulose	110	26
Benztropine Mesylate	Benztropine Mesylate	108	18
Sucralfate	Sucralfate	105	suppressed
Clopidogrel	Clopidogrel Bisulfate	104	14
Tamsulosin Hcl	Tamsulosin Hcl	99	15
Duloxetine Hcl	Duloxetine Hcl	98	13
Buspirone Hcl	Buspirone Hcl	92	21
Carbamazepine	Carbamazepine	86	suppressed
Myrbetriq	Mirabegron	82	suppressed
Metoprolol Succinate	Metoprolol Succinate	79	11
Oxybutynin Chloride Er	Oxybutynin Chloride	79	suppressed
Omeprazole	Omeprazole	78	15
Baclofen	Baclofen	77	suppressed
Gemtesa	Vibegron	76	suppressed
Januvia	Sitagliptin Phosphate	75	suppressed
Nifedipine Er	Nifedipine	75	11
Tramadol Hcl	Tramadol Hcl	75	23
Lorazepam	Lorazepam	74	25
Tradjenta	Linagliptin	72	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	70	12
Lamotrigine	Lamotrigine	68	15
Allopurinol	Allopurinol	67	suppressed
Paroxetine Hcl	Paroxetine Hcl	66	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	65	11
Latanoprost	Latanoprost	63	suppressed
Memantine Hcl Er	Memantine Hcl	60	suppressed
Spironolactone	Spironolactone	60	suppressed
Hydralazine Hcl	Hydralazine Hcl	58	15
Paliperidone Er	Paliperidone	58	suppressed
Enulose	Lactulose	57	15
Olanzapine	Olanzapine	55	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	54	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	53	12
Carbidopa-Levodopa	Carbidopa/Levodopa	51	suppressed
Amantadine	Amantadine Hcl	50	suppressed
Digoxin	Digoxin	50	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	50	suppressed
Aripiprazole	Aripiprazole	48	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	48	suppressed
Rivastigmine	Rivastigmine Tartrate	46	suppressed
Invega Sustenna	Paliperidone Palmitate	45	suppressed
Xarelto	Rivaroxaban	45	suppressed
Montelukast Sodium	Montelukast Sodium	44	suppressed
Finasteride	Finasteride	43	suppressed
Ropinirole Hcl	Ropinirole Hcl	43	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	41	13
Fluoxetine Hcl	Fluoxetine Hcl	38	suppressed
Lithium Carbonate	Lithium Carbonate	38	suppressed
Diclofenac Sodium	Diclofenac Sodium	37	suppressed
Divalproex Sodium Er	Divalproex Sodium	37	suppressed
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	36	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	35	suppressed
Velphoro	Sucroferric Oxyhydroxide	34	suppressed
Lokelma	Sodium Zirconium Cyclosilicate	33	suppressed
Ondansetron Hcl	Ondansetron Hcl	33	22
Ingrezza	Valbenazine Tosylate	32	suppressed
Atenolol	Atenolol	30	suppressed
Celecoxib	Celecoxib	28	suppressed
Humalog	Insulin Lispro	28	suppressed
Novolog Flexpen	Insulin Aspart	28	suppressed
Calcium Acetate	Calcium Acetate	27	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Glipizide	Glipizide	26	suppressed
Irbesartan	Irbesartan	26	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	25	suppressed
Rivastigmine	Rivastigmine	25	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Trintellix	Vortioxetine Hydrobromide	25	suppressed
Vascepa	Icosapent Ethyl	25	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	24	suppressed
Insulin Lispro	Insulin Lispro	24	suppressed
Fluticasone Propionate	Fluticasone Propionate	23	suppressed
Haloperidol	Haloperidol	23	suppressed
Jardiance	Empagliflozin	23	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	23	suppressed
Pregabalin	Pregabalin	23	suppressed
Abilify Maintena	Aripiprazole	22	suppressed
Admelog	Insulin Lispro	22	suppressed
Clonazepam	Clonazepam	22	suppressed
Enalapril Maleate	Enalapril Maleate	22	suppressed
Lacosamide	Lacosamide	22	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	22	suppressed
Midodrine Hcl	Midodrine Hcl	21	suppressed
Misoprostol	Misoprostol	21	suppressed
Exelon	Rivastigmine	20	suppressed
Nystatin	Nystatin	20	11
Venlafaxine Hcl Er	Venlafaxine Hcl	20	suppressed
Cefuroxime	Cefuroxime Axetil	19	13
Pravastatin Sodium	Pravastatin Sodium	19	suppressed
Benazepril Hcl	Benazepril Hcl	18	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	18	suppressed
Doxepin Hcl	Doxepin Hcl	18	suppressed
Humalog Kwikpen U-100	Insulin Lispro	18	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	18	suppressed
Alendronate Sodium	Alendronate Sodium	17	suppressed
Entresto	Sacubitril/Valsartan	17	suppressed
Fenofibrate	Fenofibrate	17	suppressed
Novolog	Insulin Aspart	17	suppressed
Permethrin	Permethrin	17	15
Prednisone	Prednisone	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	16	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	16	suppressed
Meloxicam	Meloxicam	16	suppressed
Citalopram Hbr	Citalopram Hydrobromide	15	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	15	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Premarin	Estrogens, Conjugated	15	suppressed
Trospium Chloride	Trospium Chloride	15	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	14	suppressed
Cholestyramine	Cholestyramine (With Sugar)	14	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	14	suppressed
Nuplazid	Pimavanserin Tartrate	14	suppressed
Nystop	Nystatin	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	suppressed
Alprazolam	Alprazolam	12	suppressed
Bupropion Hcl	Bupropion Hcl	12	suppressed
Dantrolene Sodium	Dantrolene Sodium	12	suppressed
Fiasp	Insulin Aspart (Niacinamide)	12	suppressed
Galantamine Er	Galantamine Hbr	12	suppressed
Levemir	Insulin Detemir	12	suppressed
Metformin Hcl Er	Metformin Hcl	12	suppressed
Prazosin Hcl	Prazosin Hcl	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	11
Tolterodine Tartrate Er	Tolterodine Tartrate	12	suppressed
Incruse Ellipta	Umeclidinium Bromide	11	suppressed
Levofloxacin	Levofloxacin	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Risperdal Consta	Risperidone Microspheres	11	suppressed
Spiriva Respimat	Tiotropium Bromide	11	suppressed
Tacrolimus	Tacrolimus	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error